Overview Natural Killer (NK) Cell Transplantation for AML Status: Completed Trial end date: 2013-03-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety and efficacy of infusing natural killer cells from a donor as treatment for patients with acute myeloid leukemia in remission or who have experienced relapse. Phase: N/A Details Lead Sponsor: St. Jude Children's Research HospitalTreatments: ClofarabineCyclophosphamideEtoposideEtoposide phosphateFludarabineFludarabine phosphateInterleukin-2